GlaxoSmithKline (GSK) Q2: Core EPS 26.4 pence. Sales -3.9% to £6.46B vs. consensus of £6.65B....


GlaxoSmithKline (GSK) Q2: Core EPS 26.4 pence. Sales -3.9% to £6.46B vs. consensus of £6.65B. Net profit +13% to £1.25B vs. consensus of £1.34B. Increases dividend by 6% to 17 pence. Shares -0.85%. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs